Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
SHPH | US
0.16
11.11%
Healthcare
Drug Manufacturers-Specialty & Generic
30/06/2024
12/09/2024
1.60
1.45
1.65
1.37
Shuttle Pharmaceuticals Holdings Inc. a clinical stage pharmaceutical company develops novel therapies to cure cancers. It develops Ropidoxuridine an oral halogenated pyrimidine to treat patients with brain tumors and sarcomas SP-1-161 an HDAC inhibitor that initiates the mutated in ataxia-telangiectasia response pathway for radiation sensitizing cancer cells and protecting normal cells; SP-2-225 a pre-clinical class IIb that effects on the regulation of the immune system; and SP-1-303 a pre-clinical selective Class I HDAC for the treatment of ER positive cancers. The company was founded in 2012 and is based in Rockville Maryland.
View LessPrice Below SMA10D
High Short-term Volatility
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
High Debt to Equity (> 0.75)
Weak Sharpe Ratio (< 0.3)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
183.8%1 month
156.2%3 months
111.0%6 months
90.8%-
-
4.53
1.44
0.41
-0.67
-
-
-5.73M
3.01M
3.01M
-
-
-
-
-152.02
0.21
1.63
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
2.02
Range1M
2.02
Range3M
3.01
Rel. volume
0.12
Price X volume
288.88K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Sonoma Pharmaceuticals Inc | SNOA | Drug Manufacturers-Specialty & Generic | 3.17 | 3.23M | -3.06% | n/a | 8.44% |
Evoke Pharma Inc | EVOK | Drug Manufacturers-Specialty & Generic | 4.19 | 3.12M | 4.23% | 0.03 | 187.62% |
Bio-Path Holdings Inc | BPTH | Drug Manufacturers-Specialty & Generic | 0.9768 | 2.49M | 0.70% | n/a | 4.26% |
China SXT Pharmaceuticals Inc | SXTC | Drug Manufacturers-Specialty & Generic | 0.66 | 2.09M | 6.62% | n/a | 19.00% |
Akanda Corp. Common Shares | AKAN | Drug Manufacturers-Specialty & Generic | 1.16 | 2.01M | 1.29% | n/a | -104.44% |
Premier Biomedical Inc | BIEI | Drug Manufacturers-Specialty & Generic | 0.0018 | 1.84M | 0.00% | n/a | -22.64% |
Lml Ltd Dematerialised | LMLLF | Drug Manufacturers-Specialty & Generic | 0.0151 | 1.54M | 17.05% | n/a | -98.67% |
PRFX | PRFX | Drug Manufacturers-Specialty & Generic | 0.83 | 1.12M | -12.63% | n/a | -2.89% |
Sunshine Biopharma Inc. Warrant | SBFMW | Drug Manufacturers-Specialty & Generic | 0.1099 | 0 | n/a | 2.46% | |
Procaps Group S.A. Warrants | PROCW | Drug Manufacturers-Specialty & Generic | 0.0201 | 0 | -32.09% | n/a | 0.00% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Forza X1 Inc | FRZA | Recreational Vehicles | 0.215 | 2.95M | -0.78% | n/a | 0.97% |
Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 1.5 | 860.26K | -5.66% | n/a | 0.00% |
Blackstone/GSO Senior Floating Rate Term Fund | BSL | Textile Manufacturing | 14.25 | 0 | -0.28% | n/a |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | -0.67 | - | Cheaper |
Ent. to Revenue | - | - | - |
PE Ratio | - | 28.13 | - |
Price to Book | 4.53 | 11.07 | Cheaper |
Dividend Yield | - | - | - |
Std. Deviation (3M) | 111.05 | - | Riskier |
Debt to Equity | 1.44 | -0.91 | Expensive |
Debt to Assets | 0.41 | 0.45 | Par |
Market Cap | 3.01M | - | Emerging |